When you receive an endometriosis diagnosis — or when you’re trying to conceive and someone suggests endo might be involved — one of the first fears that surfaces is whether having this condition means you cannot have children. It is a question that carries enormous emotional weight, and it deserves an honest, evidence-based answer rather than a reassuring vague one.
The short answer is that endometriosis does not automatically mean infertility. The longer answer is more nuanced: endo can affect fertility in specific, documented ways, and the relationship between stage, location, and conception outcome is more complex than most people are told. Understanding that complexity is not just useful — it changes how you advocate for yourself in the fertility system.
Endometriosis does not automatically mean infertility. An estimated 60–70% of women with endo are able to conceive, though fertility impact depends on disease stage, location, and individual biology. Understanding the specific mechanisms helps you ask better questions and get better care.
Key Takeaways
- Endometriosis affects an estimated 30–50% of women who experience fertility challenges, but this does not mean endo causes infertility in all cases — the relationship is probabilistic, not deterministic (American Society for Reproductive Medicine, 2022).
- Approximately 10–15% of reproductive-age women have endometriosis; of those, an estimated 30–50% will experience some degree of fertility impact (World Endometriosis Research Foundation, 2024).
- Stage III–IV endometriosis, particularly endometriomas and pelvic adhesions, has the most clearly documented negative effect on egg quality, tube patency, and implantation rates (Revised American Fertility Society Classification).
- Stage I–II endometriosis presents a more paradoxical picture: fertility impact is measurable but inconsistent — the exact mechanism is less understood and surgical benefit is more debated.
- Some women with Stage IV endometriosis conceive naturally and without intervention; others with Stage I cannot. Stage alone is not a reliable fertility predictor.
- Consistent cycle and symptom tracking can meaningfully support fertility treatment by identifying ovulation windows, flagging cycle irregularities, and building the historical data that reproductive endocrinologists rely on to personalise care.
Does Endometriosis Cause Infertility?
Infertility is defined as the inability to conceive after 12 months of unprotected intercourse (or 6 months for women over 35). Endometriosis does not cause infertility in all cases — but it is associated with reduced fertility in a significant proportion of people who have it.
The American Society for Reproductive Medicine (ASRM) estimates that 30–50% of women with endometriosis experience fertility challenges. Read that carefully: it means 50–70% do not. Many people with endo — including some with severe Stage IV disease — conceive naturally, sometimes without knowing they had the condition at all. At the same time, endometriosis is found in roughly 25–50% of infertile women undergoing investigation, making it one of the most common underlying contributors to fertility difficulty.
What endo does, mechanically speaking, is create a hostile environment — not an impossible one. It changes the biochemical conditions in the pelvis, the structural anatomy of the reproductive organs, and in some cases the quality of the eggs themselves. How much any of this matters depends on where the disease is, how extensive it is, and a range of individual biological factors that no staging system fully captures.
How Endometriosis Affects Fertility: The Biological Mechanisms
Understanding why endo affects fertility — not just that it does — is important for evaluating your options and asking the right questions at appointments.
Tubal Occlusion and Adhesions
In moderate to severe endometriosis, inflammatory lesions trigger the formation of adhesions — fibrous scar tissue that binds pelvic organs together. When adhesions form around or inside the fallopian tubes, they can distort the tubes’ anatomy, partially or completely blocking the passage of eggs from ovary to uterus.
Tubal factor infertility accounts for around 30% of female infertility cases (ASRM), and endometriosis is a major cause. In Stage III–IV disease, bilateral tubal occlusion can make natural conception mechanically impossible — but even partial distortion, which doesn’t fully block the tube, can impair the ciliary motion that guides an egg along.
Endometriomas and Ovarian Reserve
An endometrioma is an ovarian cyst formed when endometriotic tissue implants on the ovary, filling the cyst with old blood (often called a “chocolate cyst” for its appearance). Endometriomas are associated with measurably reduced ovarian reserve — the quantity and quality of eggs available for fertilisation.
Research consistently shows that women with endometriomas have lower anti-Müllerian hormone (AMH) levels — a key marker of ovarian reserve — than women with endometriosis elsewhere. Surgery to remove endometriomas can further reduce ovarian reserve if healthy ovarian tissue is inadvertently removed in the process, which is a genuine tension in the decision to operate. A 2017 review in the Journal of Human Reproduction found that women with bilateral endometriomas had significantly lower AMH than those with unilateral cysts, and that surgical excision of bilateral endometriomas was associated with further reserve reduction. The decision to operate on endometriomas prior to fertility treatment is therefore individualised and requires specialist judgment.
Peritoneal Fluid and Inflammation
Even without adhesions or endometriomas, the peritoneal environment in endometriosis is biochemically altered. The peritoneal fluid that bathes the pelvic organs contains elevated levels of inflammatory cytokines, prostaglandins, macrophages, and oxidative stress markers. This inflammatory milieu is toxic to sperm function and can impair egg quality, fertilisation, and early embryo development.
This is the most plausible mechanism by which early-stage endometriosis reduces fertility without any obvious structural cause — and it’s why Stage I–II endo can still matter reproductively, even when tubes are open and ovaries appear structurally normal on ultrasound.
Implantation Failure
Endometriosis also appears to alter the endometrium — the uterine lining where a fertilised egg implants — even when lesions are not physically inside the uterus. Studies have identified differences in endometrial receptivity markers in women with endometriosis, suggesting that even a normally fertilised embryo may have difficulty implanting. Recurrent implantation failure in IVF cycles is sometimes associated with underlying undiagnosed or inadequately treated endometriosis.
Stage I–II vs Stage III–IV: What the Research Shows
The four-stage classification of endometriosis (revised by the American Fertility Society) is primarily a surgical scoring system that reflects the extent of adhesions, ovarian involvement, and deep infiltrating disease — not a direct measure of pain or fertility potential. This creates real-world confusion.
“Some women with Stage IV endometriosis conceive naturally; others with Stage I struggle. Stage classification alone is not a reliable predictor of individual fertility outcomes.”
Stage I–II (Minimal to Mild)
Stage I and II disease involves superficial peritoneal implants with few or no adhesions. Tubes and ovaries are structurally normal or minimally affected. Theoretically, the structural barriers to conception are minimal — yet studies consistently show a reduced monthly fecundity rate (probability of conception per cycle) compared to women without endo.
The ASRM estimates that the monthly fecundity rate in women with minimal/mild endometriosis is approximately 2–10%, compared to 15–20% in the general population. The mechanism is believed to be the inflammatory peritoneal environment rather than structural blockage.
Whether laparoscopic surgery improves fertility in Stage I–II is contested. A landmark Canadian randomised controlled trial (Marcoux et al., 1997) found that treating visible Stage I–II lesions improved pregnancy rates; a subsequent Italian trial did not confirm the benefit. Current ASRM and ESHRE guidelines tentatively support treating Stage I–II disease in fertility-seeking patients, but emphasise that the benefit is modest and patient-specific.
Stage III–IV (Moderate to Severe)
Stage III–IV disease involves deep infiltrating endometriosis, significant adhesions, and frequently endometriomas. Here, the structural fertility impact is more direct and better established. Adhesions can block tubes, endometriomas can suppress ovarian reserve, and widespread disease may distort the entire pelvic anatomy.
Women with Stage III–IV endo generally have lower spontaneous conception rates than those with early-stage disease, and many reproductive endocrinologists recommend moving to assisted reproduction (IUI or IVF) more quickly rather than waiting for natural conception to occur over many cycles. The risk of further ovarian reserve damage from endometrioma recurrence or surgery is a factor in the timing of these decisions.
Treatment Options: Excision, Suppression, IUI, and IVF
Understanding your treatment options means understanding that they are not mutually exclusive — and that the sequence and combination matters for fertility outcomes.
Excision Surgery
Excision surgery (laparoscopic surgical removal of endometriotic lesions) is distinct from ablation (see our post on endometriosis surgery recovery). For fertility, the relevant question is whether removing endo tissue improves conception rates — and the evidence suggests it does, particularly for Stage III–IV disease involving adhesions and endometriomas.
A 2019 Cochrane review found that laparoscopic surgery for Stage III–IV endometriosis improved natural conception rates compared to diagnostic laparoscopy alone. For endometriomas specifically, the evidence supports surgical drainage before IVF in women with cysts over 4cm where there is concern about access to follicles during egg collection — though the decision must weigh this against the risk of ovarian reserve reduction.
The key is who performs the surgery. Excision by an endometriosis specialist (not a general gynaecologist) is consistently associated with better outcomes and lower recurrence rates. Before any fertility-related surgery, seek care from a surgeon who specialises in endo excision.
Hormonal Suppression
Hormonal treatments — the combined pill, progestogens, GnRH agonists, the Mirena IUD — effectively suppress endometriosis activity and reduce symptoms. However, they do so by suppressing ovulation, making them incompatible with trying to conceive while taking them.
The role of hormonal suppression in fertility treatment is primarily post-surgical, to reduce recurrence and preserve ovarian reserve in the window before IVF. There is no evidence that pre-IVF hormonal suppression improves live birth rates in women with endo, though some protocols use short courses of GnRH agonists before egg retrieval.
IUI (Intrauterine Insemination)
Intrauterine insemination involves placing prepared sperm directly into the uterus around the time of ovulation, improving sperm proximity to the egg. IUI is most useful when tubes are patent and the primary fertility barrier is sperm transport rather than egg quality or implantation.
For Stage I–II endometriosis with open tubes, IUI (particularly with ovarian stimulation) offers modestly improved pregnancy rates compared to timed intercourse. Success rates per cycle are typically 8–17%, depending on age and other factors. For Stage III–IV disease with structural involvement, IUI is generally less effective and many specialists move to IVF.
IVF (In Vitro Fertilisation)
IVF bypasses many of the mechanisms by which endometriosis impairs natural conception — it retrieves eggs directly from the ovaries, fertilises them in a laboratory, and transfers embryos directly to the uterus, bypassing the tubes entirely. For this reason, IVF is the most effective assisted reproduction option for most women with moderate to severe endo.
However, IVF success rates in women with endometriosis are still lower than in age-matched controls without the condition. A 2017 meta-analysis found that women with endometriosis had lower clinical pregnancy rates and live birth rates per IVF cycle than women with other indications, with the reduction being most pronounced in those with Stage III–IV disease and endometriomas. Egg quality appears to be a genuine factor, not just implantation.
The Fertility Paradox: Why Stage Doesn’t Tell the Whole Story
If you’ve been told you have Stage IV endometriosis and a friend with “mild” Stage I is struggling to conceive — while you fell pregnant naturally last year — you already understand the paradox. The staging system does not predict individual outcomes.
This happens because fertility is multifactorial. A woman with Stage IV disease may have extensive pelvic adhesions that don’t affect her tubes or ovaries at all, and her peritoneal inflammatory burden may be lower than someone with less visible Stage II disease. Conversely, someone with minimal visible disease may have profound egg quality impairment from inflammatory peritoneal fluid that doesn’t show up on any scan.
This is why specialist assessment — ideally with a reproductive endocrinologist who has experience with endo-related infertility — is more valuable than stage alone. The investigations that matter are: tubal patency testing (hysterosalpingogram or HyCoSy), ovarian reserve markers (AMH, antral follicle count), semen analysis, and in some cases endometrial receptivity testing.
How Cycle Tracking and Symptom Logging Support Your Fertility Journey
Timing matters enormously in fertility — and endometriosis complicates cycle prediction in ways that generic period apps aren’t designed to handle. Women with endo frequently have irregular cycles, anovulatory cycles (where ovulation does not occur), or cycles where ovulation occurs at unpredictable times due to hormonal disruption from endo-related inflammation.
Tracking your cycle longitudinally — not just period start dates, but ovulation signs, mid-cycle pain, libido patterns, cervical mucus changes, and symptom patterns across the full cycle — gives you and your fertility specialist far more to work with than an app that only confirms when your next period is expected.
EndoTracking includes a cycle correlation feature that maps your logged symptoms against your cycle phase, making it possible to identify patterns like consistent mid-cycle pain (which may indicate ovulation or an endometrioma), late luteal symptom escalation, or cycle-to-cycle variability that suggests anovulation. This kind of longitudinal data is exactly what a reproductive endocrinologist needs to understand what’s happening before they recommend any intervention.
Specifically, tracking over three or more cycles before a fertility consultation allows you to bring:
- Your average cycle length and variability
- Documented mid-cycle symptoms that may indicate ovulation timing
- Pain patterns mapped to cycle phase
- Any symptoms that suggest hormonal irregularity (prolonged luteal phase, very short cycles, absent ovulation signs)
- A clear record of when intercourse occurred relative to probable ovulation — useful for establishing whether timing has been optimal
This data shortens the diagnostic runway and helps your specialist make faster, better-informed decisions. See our guide on preparing for your endo specialist appointment for a full checklist of what to bring.
“Three cycles of logged data — including ovulation signs, mid-cycle symptoms, and pain mapped to cycle phase — gives a reproductive endocrinologist more clinical information than a year of unrecorded cycles.”
What to Bring to Your Reproductive Endocrinologist Appointment
A reproductive endocrinologist (RE) is a gynaecologist who has completed fellowship training in endocrine-related fertility disorders. If you have endometriosis and are trying to conceive, seeing an RE — rather than a general gynaecologist or even a general fertility specialist — gives you access to the most relevant expertise.
Before your first appointment, prepare:
- Cycle tracking data: At minimum, three cycles of logged data including period dates, ovulation signs, and symptom patterns. A printed or PDF report from your tracker makes this easy to share.
- Surgical history: If you’ve had laparoscopy, bring your operative report. This tells the RE what was found, where, and how it was treated — critical information they cannot get from your GP referral alone.
- Imaging reports: Any ultrasound reports showing endometriomas, ovarian morphology, or uterine findings.
- Previous investigations: AMH, FSH, LH, antral follicle count if previously tested; semen analysis for your partner if applicable.
- Medication history: What hormonal treatments you’ve used, for how long, and your response.
During the appointment, the questions worth asking include:
- What is your assessment of how endo is likely affecting my fertility specifically?
- Do you recommend surgery before assisted reproduction, and what are the ovarian reserve implications?
- What assisted reproduction pathway would you recommend given my situation?
- If we try IVF, how does my endo stage affect the protocol and expected success rate?
- What can I do in the next 3–6 months to preserve or improve my ovarian reserve?
An informed patient gets better answers. Your cycle and symptom data — particularly if logged consistently in an app like EndoTracking — gives you something concrete to discuss rather than relying on recalled impressions of how you’ve been feeling.
Endometriosis, Fertility Preservation, and the Decision to Wait
Not everyone with endometriosis is trying to conceive right now. Many younger people receive an endo diagnosis long before they are ready for or interested in pregnancy — and the question of whether and how to preserve fertility is relevant but different.
Egg freezing (oocyte cryopreservation) is a legitimate option for women with endometriosis who want to preserve reproductive options before endo progression or necessary surgery further reduces ovarian reserve. The Endometriosis Foundation of America (EFA) and ESHRE both include fertility preservation in their guidance for women with Stage III–IV disease, particularly those with endometriomas.
The timing question is worth discussing with an RE: in some cases, earlier egg retrieval (before surgery that may reduce ovarian reserve) is advisable. In others, surgery to remove endometriomas and reduce endo burden first may improve egg quality for retrieval. This is not a decision that generalises — it requires individual assessment.
There Is No Single Fertility Outcome for Endometriosis
The research does not support a blanket prognosis. What it supports is this: endometriosis is associated with reduced fertility in a significant proportion of those who have it; the mechanisms are documented and understandable; and the options for addressing those mechanisms are more varied and more effective than they were even a decade ago.
If you have endometriosis and want to become pregnant, the most important step is specialist assessment — not waiting, not assuming the worst, and not assuming everything will work out without investigation. A reproductive endocrinologist who understands endo can give you a personalised picture based on your staging, imaging, ovarian reserve, and cycle history that no article can provide.
What you can do right now is build that cycle history. The more data you bring to that first appointment, the faster and better the care you receive. Understanding your endometriosis symptoms and tracking them consistently is one of the highest-return things you can do for your fertility journey — because it turns lived experience into clinical evidence.
Frequently Asked Questions
Can you get pregnant naturally with endometriosis?
Yes — many people with endometriosis conceive naturally. Estimates suggest that 60–70% of women with endo are able to conceive, though often it takes longer or requires more deliberate cycle timing. Fertility impact depends on disease location, stage, and individual factors. If you’ve been trying to conceive for 6–12 months without success, a fertility evaluation is appropriate regardless of endo stage.
Does endometriosis stage predict fertility outcomes?
Stage is a rough guide, not a reliable individual predictor. Stage III–IV disease — particularly with endometriomas and tubal adhesions — has more clearly documented fertility impact. Stage I–II disease reduces monthly conception probability through inflammatory mechanisms but doesn’t preclude natural conception. Many women with Stage IV conceive; many with Stage I need assistance.
Should I have surgery before trying to conceive?
This depends on your specific situation and is best answered by a reproductive endocrinologist. For Stage III–IV disease with significant adhesions or endometriomas over 4cm, surgery may improve natural conception rates and IVF success. For Stage I–II, the evidence is less clear and the decision is more nuanced. Surgeon expertise matters enormously for fertility outcomes post-operatively.
Does IVF work for endometriosis?
IVF bypasses many of the mechanical barriers endo creates (blocked tubes, etc.) and is an effective option for many women with endo. Success rates are somewhat lower than in age-matched women without endo, particularly in Stage III–IV, but IVF still achieves live births in a significant proportion of endo patients. Optimal protocol may differ from standard IVF and should be guided by an RE with endo experience.
How does endometriosis affect egg quality?
The inflammatory peritoneal environment in endometriosis generates oxidative stress and cytokines that can impair oocyte (egg) development and quality. Endometriomas in particular are associated with local oxidative stress within the ovary. This is one reason why IVF success rates in severe endo may be lower even when embryos are transferred — the egg quality issue precedes fertilisation.
EndoTracking is a personal health tracking app and does not provide medical or fertility advice. For personalised care, consult a reproductive endocrinologist or endometriosis specialist.